Patent · US Active

FSH glycosylation variant D3N

US7956034B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

MERCK SERONO SA · CH

Inventors

Marco Muda · Cambridge, US
Xuliang Jiang · Braintree, US
Sean D. McKenna · Duxbury, US

Key dates

Filing date	Jan 16, 2007
Grant date	Jun 7, 2011
Priority date	—
Expiry date	Jan 16, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

FSH mutant with increased glycosylation and longer half-life is described. The use of this FSH mutant for inducing folliculogenesis in human patients is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.